Given the clear importance of the JAK–STAT pathway and their interplay with chromatin remodeling enzymes in the initiation and progression of cancer, targeting of STAT3 and/or STAT5 is of high therapeutic relevance. This evidence concerns the gene STAT3 and cancer.